Activation of p38 MAPK and/or JNK contributes to increased levels of VEGF secretion in human malignant glioma cells

International Journal of Oncology

Volumn 29, Issue 4, 2006, Pages 981-987

  Yoshino, Yoshikazu ^a   Aoyagi, Masaru ^a   Tamaki, Masashi ^a   Duan, Lian ^a   Morimoto, Takashi ^a   Ohno, Kikuo ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

JNK; Malignant gliomas; p38 MAPK; VEGF

Indexed keywords

CYCLOOXYGENASE 2; INTERLEUKIN 1BETA; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE INHIBITOR; PTGS2 PROTEIN, HUMAN; VASCULOTROPIN A;

ARTICLE; BRAIN TUMOR; DRUG ANTAGONISM; ENZYME ACTIVATION; ENZYMOLOGY; GENETICS; GLIOMA; HUMAN; METABOLISM; PHOSPHORYLATION; SECRETION; TUMOR CELL LINE;

BRAIN NEOPLASMS; CELL LINE, TUMOR; CYCLOOXYGENASE 2; ENZYME ACTIVATION; GLIOMA; HUMANS; INTERLEUKIN-1BETA; MAP KINASE KINASE 4; MEMBRANE PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASE 3; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 34547673869     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.29.4.981     Document Type: Article

References (46)

1. Black PM: Brain tumor. Part 2. N Engl J Med 324: 1555-1564, 1991.
2. Wakimoto H, Aoyagi M, Nakayama T, Nagashima G, Yamamoto S, Tamaki M and Hirakawa K: Prognostic significance of Ki-67 labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas. Cancer 77: 373-380, 1996. (Pubitemid 26025528)
3. Brat DJ and van Meir EG: Glomeruloid microvascular proliferation orchestrated by VPF/VEGF: a new world of angiogenesis research. Am J Pathol 158: 789-796, 2001.
4. Kleihues P, Burger PC, Collins VP, et al: Glioblastoma. In: Pathology and Genetics of Tumors of the Nervous System. Kleihues P and Cavenee WK (eds). IARC, Lyon, pp29-39, 2000.
5. Plate KH, Breier G, Weich HA and Risau W: Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359: 845-848, 1992.
6. Shweiki D, Itin A, Soffer D and Keshet E: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359: 843-845, 1992.
7. Pietsch T, Valter MM, Wolf HK, von Deimling A, Huang HJ, Cavenee WK and Wiestler OD: Expression and distribution of vascular endothelial growth factor protein in human brain tumors. Acta Neuropathol 93: 109-117, 1997. (Pubitemid 27060902)
8. Cheng SY, Huang HJ, Nagane M, Ji XD, Wang D, Shih CC, Arap W, Huang CM and Cavenee WK: Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor. Proc Natl Acad Sci USA 93: 8502-8507, 1996.
9. Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS and Ferrara N: Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362: 841-844, 1993. (Pubitemid 23132159)
10. Millauer B, Shawver LK, Plate KH, Risau W and Ullrich A: Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature 367: 576-579, 1994.
11. Saleh M, Stacker SA and Wilks AF: Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence. Cancer Res 56: 393-401, 1996.
12. Damert A, Ikeda E and Risau W: Activator-protein-1 binding potentiates the hypoxia-induciblefactor-1-mediated hypoxia-induced transcriptional activation of vascular-endothelial growth factor expression in C6 glioma cells. Biochem J 327: 419-423, 1997. (Pubitemid 27477817)
13. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD and Semenza GL: Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16: 4604-4613, 1996. (Pubitemid 26272112)
14. Feldkamp MM, Lau N, Rak J, Kerbel RS and Guha A: Normoxic and hypoxic regulation of vascular endothelial growth factor (VEGF) by astrocytoma cells is mediated by Ras. Int J Cancer 81: 118-124, 1999. (Pubitemid 29124206)
15. Dunn IF, Heese O and Black PM: Growth factors in glioma angiogenesis: FGFs, PDGF, EGF, and TGFs. J Neurooncol 50: 121-137, 2000. (Pubitemid 32169649)
16. Maity A, Pore N, Lee J, Solomon D and O'Rourke DM: Epidermal growth factor receptor transcriptionally up-regulates vascular endothelial growth factor expression in human glioblastoma cells via a pathway involving phosphatidylinositol 3′-kinase and distinct from that induced by hypoxia. Cancer Res 60: 5879-5886, 2000.
17. Moriyama T, Kataoka H, Hamasuna R, Yokogami K, Uehara H, Kawano H, Goya T, Tsubouchi H, Koono M and Wakisaka S: Upregulation of vascular endothelial growth factor induced by hepatocyte growth factor/scatter factor stimulation in human glioma cells. Biochem Biophys Res Commun 249: 73-77, 1998.
18. Neufeld G, Cohen T, Gengrinovitch S and Poltorak Z: Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13: 9-22, 1999.
19. Ryuto M, Ono M, Izumi H, Yoshida S, Weich HA, Kohno K and Kuwano M: Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells. Possible roles of SP-1. J Biol Chem 271: 28220-28228, 1996.
20. Valter MM, Wiestler OD and Pietsch T: Differential control of VEGF synthesis and secretion in human glioma cells by IL-1 and EGF. Int J Dev Neurosci 17: 565-577, 1999.
21. Franke TF, Kaplan DR, Cantley LC and Toker A: Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate. Science 275: 665-668, 1997.
22. Mazure NM, Chen EY, Laderoute KR and Giaccia AJ: Induction of vascular endothelial growth factor by hypoxia is modulated by a phosphatidylinositol 3-kinase/Akt signaling pathway in Ha-ras-transformed cells through a hypoxia inducible factor-1 transcriptional element. Blood 90: 3322-3331, 1997.
23. Majima M, Hayashi I, Muramatsu M, Katada J, Yamashina S and Katori M: Cyclo-oxygenase-2 enhances basic fibroblast growth factor-induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants. Br J Pharmacol 130: 641-649, 2000.
24. Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M and DuBois RN: Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93: 705-716, 1998.
25. Hara A and Okayasu I: Cyclooxygenase-2 and inducible nitric oxide synthase expression in human astrocytic gliomas: correlation with angiogenesis and prognostic significance. Acta Neuropathol 108: 43-48, 2004.
26. Joki T, Heese O, Nikas DC, Bello L, Zhang J, Kraeft SK, Seyfried NT, Abe T, Chen LB, Carroll RS and Black PM: Expression of cyclooxygenase 2 (COX-2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398. Cancer Res 60: 4926-4931, 2000.
27. Shono T, Tofilon PJ, Bruner JM, Owolabi O and Lang FF: Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations. Cancer Res 61: 4375-4381, 2001.
28. Blumer KJ and Johnson GL: Diversity in function and regulation of MAP kinase pathways. Trends Biochem Sci 19: 236-240, 1994.
29. Tsuji F, Oki K, Senda T, Horiuchi M and Mita S: Effects of mitogen-activated protein kinase inhibitors or phosphodiesterase inhibitors on interleukin-1-induced cytokines production in synovium-derived cells. Immunol Lett 68: 275-279, 1999.
30. Xu L, Fukumura D and Jain RK: Acidic extracellular pH induces vascular endothelial growth factor (VEGF) in human glioblastoma cells via ERK1/2 MAPK signaling pathway: mechanism of low pH-induced VEGF. J Biol Chem 277: 11368-11374, 2002.
31. Cobb MH and Goldsmith EJ: How MAP kinases are regulated. J Biol Chem 270: 14843-14846, 1995.
32. Yamamoto K, Yamamoto M and Ooka H: Changes in negative surface charge of human diploid fibroblasts, TIG-1, during in vitro aging. Mech Ageing Dev 42: 183-195, 1988.
33. Duan L, Aoyagi M, Tamaki M, Nakagawa K, Nagashima G, Nagasaka Y, Ohno K, Yamamoto K and Hirakawa K: Sensitization of human malignant glioma cell lines to tumor necrosis factor-induced apoptosis by cisplatin. J Neurooncol 52: 23-36, 2001.
34. Marshall CJ: Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80: 179-185, 1995.
35. Raingeaud J, Gupta S, Rogers JS, Dickens M, Han J, Ulevitch RJ and Davis RJ: Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 270: 7420-7426, 1995.
36. Nagineni CN, Samuel W, Nagineni S, Pardhasaradhi K, Wiggert B, Detrick B and Hooks JJ: Transforming growth factor-beta induces expression of vascular endothelial growth factor in human retinal pigment epithelial cells: involvement of mitogen-activated protein kinases. J Cell Physiol 197: 453-462, 2003.
37. Mori K, Tani M, Kamata K, Kawamura H, Urata Y, Goto S, Kuwano M, Shibata S and Kondo T: Mitogen-activated protein kinase, ERK1/2, is essential for the induction of vascular endothelial growth factor by ionizing radiation mediated by activator protein-1 in human glioblastoma cells. Free Radic Res 33: 157-166, 2000.
38. Mandell JW, Hussaini IM, Zecevic M, Weber MJ and VandenBerg SR: In situ visualization of intratumor growth factor signaling: immunohistochemical localization of activated ERK/MAP kinase in glial neoplasms. Am J Pathol 153: 1411-1423, 1998.
39. Gille J, Swerlick RA and Caughman SW: Transforming growth factor-alpha-induced transcriptional activation of the vascular permeability factor (VPF/VEGF) gene requires AP-2-dependent DNA binding and transactivation. EMBO J 16: 750-759, 1997. (Pubitemid 27089522)
40. Tanaka T, Kanai H, Sekiguchi K, Aihara Y, Yokoyama T, Arai M, Kanda T, Nagai R and Kurabayashi M: Induction of VEGF gene transcription by IL-1 beta is mediated through ttress-activated MAP tinases and Sp1 sites in cardiac myocytes. J Mol Cell Cardiol 32: 1955-1967, 2000.
41. Tischer E, Mitchell R, Hartman T, Silva M, Gospodarowicz D, Fiddes JC and Abraham JA: The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 266: 11947-11954, 1991.
42. Xiong S, Grijalva R, Zhang L, Nguyen NT, Pisters PW, Pollock RE and Yu D: Up-regulation of vascular endothelial growth factor in breast cancer cells by the heregulin-beta1-activated p38 signaling pathway enhances endothelial cell migration. Cancer Res 61: 1727-1732, 2001. (Pubitemid 34292611)
43. Okajima E and Thorgeirsson UP: Different regulation of vascular endothelial growth factor expression by the ERK and p38 kinase pathways in v-ras, v-raf, and v-myc transformed cells. Biochem Biophys Res Commun 270: 108-111, 2000. (Pubitemid 30440400)
44. La Rocca RV, Rosenblum M, Westermark B and Israel MA: Patterns of proto-oncogene expression in human glioma cell lines. J Neurosci Res 24: 97-106, 1989. (Pubitemid 19262391)
45. Black KL, Chen K, Becker DP and Merrill JE: Inflammatory leukocytes associated with increased immunosuppression by glioblastoma. J Neurosurg 77: 120-126, 1992.
46. Chung IY and Benveniste EN: Tumor necrosis factor-alpha production by astrocytes. Induction by lipopolysaccharide, IFN-gamma, and IL-1 beta. J Immunol 144: 2999-3007, 1990.